Elan (ELN +1.3%) spiked a bit just before the close after Reuters reported Allergan (AGN +1.2%) and Forest Labs (FRX +0.3%) remain interested in the company, which will seek first-round bids next week. Mylan and Endo Health are reportedly no longer interested. Allergan and Forest are said to be considering bids due to Ireland's low corporate tax rates. (previous)